Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $768000.0.

  • Utah Medical Products' Accounts Payables fell 2312.31% to $768000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $768000.0, marking a year-over-year decrease of 2312.31%. This contributed to the annual value of $696000.0 for FY2024, which is 949.28% down from last year.
  • Latest data reveals that Utah Medical Products reported Accounts Payables of $768000.0 as of Q3 2025, which was down 2312.31% from $737000.0 recorded in Q2 2025.
  • Utah Medical Products' 5-year Accounts Payables high stood at $1.5 million for Q1 2022, and its period low was $511000.0 during Q3 2023.
  • In the last 5 years, Utah Medical Products' Accounts Payables had a median value of $914000.0 in 2025 and averaged $956894.7.
  • Its Accounts Payables has fluctuated over the past 5 years, first soared by 11178.57% in 2021, then crashed by 6035.69% in 2023.
  • Quarter analysis of 5 years shows Utah Medical Products' Accounts Payables stood at $761000.0 in 2021, then skyrocketed by 60.05% to $1.2 million in 2022, then crashed by 36.86% to $769000.0 in 2023, then fell by 9.49% to $696000.0 in 2024, then grew by 10.34% to $768000.0 in 2025.
  • Its Accounts Payables stands at $768000.0 for Q3 2025, versus $737000.0 for Q2 2025 and $914000.0 for Q1 2025.